Similar articles for PMID: 16619517

Year	Number of Results
1959	1
1987	1
1991	1
1992	1
1998	3
1999	4
2000	2
2001	10
2002	4
2003	23
2004	29
2005	50
2006	56
2007	22
2008	15
2009	12
2010	5
2011	2
2012	4
2013	7
2014	3
2015	4
2016	6
2017	2
2018	1
2019	1
2020	1
2024	0

1

C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.

Mikami T, Koyama T, Koyama T, Imakiire A, Yamamoto K, Furuhata M, Toyota H, Mizuguchi J. Mikami T, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1153-60. Anticancer Res. 2006. PMID: 16619517 Free article.

2

Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.

Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J. Hotta T, et al. J Orthop Res. 2003 Sep;21(5):949-57. doi: 10.1016/S0736-0266(03)00062-7. J Orthop Res. 2003. PMID: 12919886 Free article.

3

Apoptosis induced by chemotherapeutic agents involves c-Jun N-terminal kinase activation in sarcoma cell lines.

Koyama T, Mikami T, Koyama T, Imakiire A, Yamamoto K, Toyota H, Mizuguchi J. Koyama T, et al. J Orthop Res. 2006 Jun;24(6):1153-62. doi: 10.1002/jor.20176. J Orthop Res. 2006. PMID: 16705697 Free article.

4

Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.

Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P. Zhang XD, et al. Clin Cancer Res. 2006 Feb 15;12(4):1355-64. doi: 10.1158/1078-0432.CCR-05-2084. Clin Cancer Res. 2006. PMID: 16489094

5

Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.

Yanase N, Hata K, Shimo K, Hayashida M, Evers BM, Mizuguchi J. Yanase N, et al. Exp Cell Res. 2005 Oct 15;310(1):10-21. doi: 10.1016/j.yexcr.2005.06.021. Exp Cell Res. 2005. PMID: 16099454

6

Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.

Meurette O, Lefeuvre-Orfila L, Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT. Meurette O, et al. Clin Cancer Res. 2005 Apr 15;11(8):3075-83. doi: 10.1158/1078-0432.CCR-04-1764. Clin Cancer Res. 2005. PMID: 15837763

7

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

Cuello M, Ettenberg SA, Nau MM, Lipkowitz S. Cuello M, et al. Gynecol Oncol. 2001 Jun;81(3):380-90. doi: 10.1006/gyno.2001.6194. Gynecol Oncol. 2001. PMID: 11371126

8

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S. Keane MM, et al. Cancer Res. 1999 Feb 1;59(3):734-41. Cancer Res. 1999. PMID: 9973225

9

Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.

Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. Singh TR, et al. Cancer Res. 2003 Sep 1;63(17):5390-400. Cancer Res. 2003. PMID: 14500373

10

Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.

Panichakul T, Intachote P, Wongkajorsilp A, Sripa B, Sirisinha S. Panichakul T, et al. Anticancer Res. 2006 Jan-Feb;26(1A):259-65. Anticancer Res. 2006. PMID: 16475706 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

256 results

Results by year